| human | Q5 |
| P9956 | IRIS Sapienza author ID | 12547 |
| P496 | ORCID iD | 0000-0002-6597-0265 |
| P11597 | Padua Research Archive author ID | 63995 |
| P1053 | ResearcherID | F-4655-2014 |
| P1153 | Scopus author ID | 26637447600 |
| P734 | family name | Del Bianco | Q98214138 |
| Del Bianco | Q98214138 | ||
| Del Bianco | Q98214138 | ||
| P735 | given name | ??? | Q13137395 |
| ??? | Q13137395 | ||
| P106 | occupation | researcher | Q1650915 |
| P21 | sex or gender | female | Q6581072 |
| Q44389799 | A multidisciplinary approach to improve preoperative understanding and reduce anxiety: a randomised study. |
| Q46491142 | A phase I-II study of weekly oxaliplatin, 5-fluorouracil continuous infusion and preoperative radiotherapy in locally advanced rectal cancer. |
| Q52329501 | BRAF gene copy number and mutant allele frequency correlate with time to progression in metastatic melanoma patients treated with MAPK inhibitors. |
| Q47817610 | Circulating cell-free DNA, SLC5A8 and SLC26A4 hypermethylation, BRAF(V600E): A non-invasive tool panel for early detection of thyroid cancer |
| Q51490667 | Circulating cell-free DNA: a promising marker of pathologic tumor response in rectal cancer patients receiving preoperative chemoradiotherapy. |
| Q54394872 | Circulating cell-free DNA: a promising marker of regional lymphonode metastasis in breast cancer patients. |
| Q64892564 | Circulating miRNA-375 as a potential novel biomarker for active Kaposi's sarcoma in AIDS patients. |
| Q58486129 | Clinical impact of false-negative sentinel lymph nodes in breast cancer |
| Q35529674 | Clinical predictive circulating peptides in rectal cancer patients treated with neoadjuvant chemoradiotherapy |
| Q40678551 | Effect of antiadhesive agents on peritoneal carcinomatosis in an experimental model. |
| Q38863161 | Epstein-Barr virus load in children infected with human immunodeficiency virus type 1 in Uganda. |
| Q101046600 | Genetic Variants of the TERT Gene, Telomere Length, and Circulating TERT as Prognostic Markers in Rectal Cancer Patients |
| Q43580883 | Health-related quality of life outcomes in disease-free survivors of mid-low rectal cancer after curative surgery |
| Q49116360 | Health-related quality of life, faecal continence and bowel function in rectal cancer patients after chemoradiotherapy followed by radical surgery. |
| Q91146000 | Immune activation, immune senescence and levels of Epstein Barr Virus in kidney transplant patients: Impact of mTOR inhibitors |
| Q104108969 | Long-Term Outcomes of Induction Chemotherapy Followed by Chemo-Radiotherapy as Intensive Neoadjuvant Protocol in Patients with Esophageal Cancer |
| Q46339997 | Multi-center phase II trial of chemo-radiotherapy with 5-fluorouracil, leucovorin and oxaliplatin in locally advanced esophageal cancer. |
| Q39808820 | Patient-reported outcomes after neoadjuvant chemoradiotherapy for rectal cancer: a multicenter prospective observational study. |
| Q90007152 | Periostin and Epithelial-Mesenchymal Transition Score as Novel Prognostic Markers for Leiomyosarcoma, Myxofibrosarcoma and Undifferentiated Pleomorphic Sarcoma |
| Q96229089 | Phosphorylated Acetyl-CoA Carboxylase is associated with clinical benefit with Regorafenib in relapsed glioblastoma: REGOMA Trial Biomarker Analysis |
| Q58276206 | Polymorphisms of innate immunity genes influence disease progression in HIV-1-infected children |
| Q101048716 | Prognostic Stratification of Bladder Cancer Patients with a MicroRNA-based Approach |
| Q53067555 | Prospective assessment of imaging after preoperative chemoradiotherapy for rectal cancer. |
| Q48782637 | Psychological well-being outcomes in disease-free survivors of mid-low rectal cancer following curative surgery |
| Q48068924 | Quality of life after surgery for rectal cancer |
| Q54507719 | Relationship between tumor and plasma levels of hTERT mRNA in patients with colorectal cancer: implications for monitoring of neoplastic disease. |
| Q80839230 | Role of resection margins in patients treated with breast conservation surgery |
| Q24797727 | Sentinel node biopsy for breast cancer: is it already a standard of care? A survey of current practice in an Italian region |
| Q61884165 | Survivin expression impacts prognostically on NSCLC but not SCLC |
| Q83278267 | Survivin in esophageal cancer: An accurate prognostic marker for squamous cell carcinoma but not adenocarcinoma |
| Q91923588 | TERT Promoter Mutations Differently Correlate with the Clinical Outcome of MAPK Inhibitor-Treated Melanoma Patients |
| Q35643026 | Telomere length and telomerase levels delineate subgroups of B-cell chronic lymphocytic leukemia with different biological characteristics and clinical outcomes |
| Q34409877 | The role of genetic variants of Stromal cell-Derived Factor 1 in pediatric HIV-1 infection and disease progression |
| Q33234917 | Tolerability of intensified intravenous interferon alfa-2b versus the ECOG 1684 schedule as adjuvant therapy for stage III melanoma: a randomized phase III Italian Melanoma Inter-group trial (IMI - Mel.A.) [ISRCTN75125874] |
| Q43329523 | Validity and reliability of the MSKCC Bowel Function instrument in a sample of Italian rectal cancer patients. |
Search more.